Retagliptin phosphate

Overview

Retagliptin phosphate (SP2086 phosphate) is a selective, competitive and orally active dipeptidyl peptidase-4 ( DPP-4 ) inhibitor. Retagliptin phosphate can be used for type 2 diabetes mellitus (T2DM) research.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > SARS-CoV-2 Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Dipeptidyl Peptidase

Product Information

• Catalog No.: HY-112668
• CAS No.: 1256756-88-3
• Molecular Formula: C19H21F6N4O7P
• Molecular Weight: 562.36
• Purity: 99.71%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.08 mg/mL (3.70 mM); Clear solution
• Availability: In-stock

Source

Original product source